Pseudomonas aeruginosa is a major cause of hospital infections and is the pathogen most commonly associated with mortality in cystic fibrosis patients. Infections with this organism are very difficult to treat due to its high intrinsic antibiotic resistance. Fluoroquinolones, such as ciprofloxacin, are broadspectrum antimicrobials that target the bacterial enzymes DNA gyrase and topoisomerase IV (6) and are clinically used to treat chronic P. aeruginosa infections in cystic fibrosis patients (5, 9) . The massive use of fluoroquinolones has led to increased quinolone resistance in P. aeruginosa (18) as well as multidrug resistance, a serious problem in the clinic. Certain mutations that lead to ciprofloxacin supersusceptibility (e.g., lon [1] ) or resistance (e.g., mutations in the genes for the target topoisomerase enzymes or the upregulation of efflux pump expression [10] ) are already known. In addition, subinhibitory concentrations of fluoroquinolones play an important role in the development of resistance, in that P. aeruginosa cultures pretreated with subinhibitory concentrations of ciprofloxacin develop an adaptive resistance phenotype (1) .
It has been proposed that antibiotics rarely have a simple mechanism of action. Microarray studies indicate that they lead to the upregulation of dozens to hundreds of genes when they are used at concentrations at or near the MIC (3, 4, 14) . It has been suggested that some of these genes are involved in target inhibition, others are involved with the induction of cellular stress pathways, and some are involved with defensive measures that the bacterium takes to resist the actions of antibiotics. In this view of antibiotic action, it seems likely that there should be many more genes that are involved in increased or decreased susceptibility in bacteria than have previously been supposed and that some of these might have clinical relevance.
Therefore, in the present study we screened a comprehensive PA14 transposon mutant library (13) for mutants that showed either increased susceptibility (reflecting intrinsic resistance) or decreased susceptibility (reflecting mutational resistance) to ciprofloxacin as a survey to reveal the extent of the ciprofloxacin resistome. Freshly diluted overnight cultures were used to inoculate approximately 3 ϫ 10 4 cells per spot on to Mueller-Hinton agar plates containing ciprofloxacin at 0.025 g/ml (half the MIC for the parent strain) to screen for increased susceptibility and at 0.2 g/ml to screen for decreased susceptibility. The mutants identified by this approach were confirmed to show a changed susceptibility by determination of the MICs (17) , and changes as small as twofold were taken into account. We acknowledge that twofold changes in MICs are generally considered within the error of the standard assessment protocols. However, only results for those mutants for which we could consistently confirm changes in at least three independent measurements are shown. Growth was measured in liquid medium at 37°C by using a Tecan Spectrafluor Plus apparatus by measuring the absorbance at 620 nm every 18 min for 24 h under shaking conditions.
The first ciprofloxacin screen at 0.025 g/ml yielded a total of 62 mutants with an inability to grow in the plate assay, leading to 28 confirmed mutants with an increase in susceptibility (Table 1 ). An additional seven mutants were identified by specifically measuring the MIC of ciprofloxacin for mutants with mutations in the same operon as that for the mutants that appeared in the screen, for a total of 35 mutants ( Fig. 1 ; Table  1 ). Mutants with mutations located in an operon might exhibit polar effects.
The majority of these mutants demonstrated only twofold changes in susceptibility, although a mutant with a mutation in ftsK was eightfold more susceptible. Noticeable among the ciprofloxacin mutants with increased susceptibility was the number of mutants with mutations that were involved in DNA replication and repair, such as the Holliday junction helicase ruvA, the ATP-dependent RNA helicase recG, the recombinase xerD, and the site-specific recombinase sss. In addition, we observed the major intrinsic multidrug efflux pump mexAB-oprM, the recently identified lon mutant (1), and three other genes (namely, tig, clpP, and clpX) in the same operon. clpP and clpX encode ATP-dependent proteases like Lon. Not surprisingly, a few mutants (e.g., sss, xerD, ftsK, and ruvA mutants) showed somewhat slower growth than the wild-type strain PA14. However, all of these mutants remained more susceptible even after 48 h, while several of the other slower-growing mutants tested were not more susceptible to ciprofloxacin, indicating that slow growth did not cause increased ciprofloxacin susceptibility per se.
The constellation of genes involved in intrinsic resistance is demonstrated in Fig. 1 , which indicates that these genes were spread throughout the chromosome. Although the highthroughput nature of this screen did not permit us to complement each mutant, we were able to confirm the increased susceptible phenotype with several independent isolates from a Note that these are the original assignments for these gene mutations and were not confirmed again in this study, although the mutants were used as obtained with minimal subculture. We could also confirm 10 mutations in operons or an overlap between libraries. The mutants with the underlined mutations were tested after the initial screen due to the presence of mutations in an operonic relationship with genes that, when they were altered, influenced susceptibility to ciprofloxacin.
b A/P, adaptation, protection; TSM, transport of small molecules; TM, translation, posttranslational modification; PE, putative enzyme; TR, transcriptional regulator; HYP, hypothetical protein; MP, membrane protein; EM, energy metabolism; DRR, DNA replication recombination; CCC, carbon compound metabolism; CD, cell division; NB, nucleotide biosynthesis and metabolism; M/A, motility and attachment; AB, antibiotic resistance and susceptibility; TCRS, two-component regulatory systems; HSP, chaperones and heat shock proteins.
c ϩϩ, normal growth rate compared to that of the wild type; (ϩϩ), normal growth rate compared to that of the wild type but reduced yield; ϩ, reduced growth rate compared to that of the wild type.
d Data are from previous reports (1, 2). All P. aeruginosa genes were differentially expressed by treatment with 0.3ϫ MIC (*) and 1ϫ MIC (#) of ciprofloxacin. The direction of the arrow indicates the trend of expression relative to that by untreated cells.
e Change in susceptibility observed after 48 h.
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the PAO1 lux mutant library (12) and also confirmed the existence of multiple mutants with mutations in five operons. Interestingly, as predicted, we were able to demonstrate that 10 of the genes giving rise to an increase in susceptibility upon transposon mutation were among those differentially expressed in response to ciprofloxacin on our previous microarrays (2) . Even though the mutant with a mutation in clpP showed only a twofold altered susceptibility, it could be successfully complemented with the cloned gene. We also successfully complemented with the cloned gene the mutant that had a fleS mutation that showed a stable twofold increase in susceptibility to ciprofloxacin and norfloxacin compared to that of the wild-type strain PAO1 and for which the killing rate by ciprofloxacin was increased compared to that for the wild-type strain PAO1. FleS is known to be involved in the regulation of flagellum biosynthesis (15); and we were also able to complement a major defect in swarming motility, an ability to swarm somewhat on swimming medium, and an observed 60% decrease in static biofilm formation compared to that by wildtype strain PAO1 (data not shown). Screening of the library for mutants that showed at least a twofold decrease in susceptibility to ciprofloxacin identified 46 mutants. A further 13 mutants with mutations in adjacent genes in operons and 20 mutants with phage-related mutations were included, for a total of 79 mutants with decreased susceptibility ( Fig. 1; Table 2 ). It is worth noting that such a high-throughput approach is applicable only for genes for which the complete loss of the protein is practical (i.e., nonessential genes). Indeed, nearly all mutants with decreased susceptibility tested were able to grow as well as the wild type (Table 2) . We were able to identify previously known genes such as the mexCD-oprJ efflux regulator nfxB, mutators mutS and mutL, and the phage-related mutations and observed multiple mutations in nine operons, including the nuoD NADH dehydrogenase operon. We also observed mutations in several iron transport genes, consistent with recent views suggesting roles for free radicals in antibiotic killing (7, 11) . Among the genes giving rise to decreased susceptibility upon transposon mutation, we found 32 that were differentially expressed in response to ciprofloxacin (2) . It should be noted that while the library was quite comprehensive, it was not complete; e.g., a mutation in the mexS gene that regulates the MexEF-OprN efflux operon was not available. The resistome comprises all genes that, when they are mutated, give rise to altered susceptibility. The present survey indicates for the first time that the resistome for ciprofloxacin in P. aeruginosa is very large; i.e., it comprises more than 100 genes. It is important to note that while we have not demonstrated that these mechanisms are clinically relevant, they do indicate the enormous gene pool that can influence susceptibility to this antibiotic class. Where this may become important is in understanding two complex clinical phenomena, namely, MIC creep (in which the background level of intrinsic resistance to a given antibiotic in a population of clinical isolates rises over time) and adaptive resistance (in which the level of resistance is affected by environmental factors, such as growth in vivo or exposure to antibiotics at sub-MIC). MIC creep has previously been supposed to represent the accumulation of mutations over time (5, 8) and differs from obvious clinical resistance, which is caused by breakthrough mutations (e.g., efflux pump overexpression mutations) that cause very large changes in susceptibility. Adaptive resistance has also been proposed to represent a complex phenomenon in which multiple genes that influence gene expression can combine to induce resistance. Indeed, no fewer than 43 of the genes that gave rise to altered ciprofloxacin susceptibility were included in the list of those that are differentially expressed in P. aeruginosa in the presence of ciprofloxacin (2), which is known to promote adaptive resistance to itself. By performing a broad survey, as described here, we have provided much food for thought, and it will be essential in future studies to follow up these observations with detailed studies to determine if these candidate mutations are indeed relevant to clinically meaningful antibiotic resistance.
